Polymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individuals

dc.creatorVelozo, Camila de Almeida
dc.creatorAlmeida, Tailah Bernardo de
dc.creatorAzevedo, Marcelo Costa Velho Mendes de
dc.creatorEspasandin, Isabela
dc.creatorPinto, Jorge Francisco da Cunha
dc.creatorLópez, Sheila
dc.creatorPizzatti, Luciana
dc.creatorTanuri, Amilcar
dc.creatorSantos, Sabrina da Silva
dc.creatorRibeiro-Alves, Marcelo
dc.creatorCardoso, Cynthia Chester
dc.date.accessioned2022-08-19T01:29:34Z
dc.date.accessioned2023-09-05T12:20:19Z
dc.date.available2022-08-19T01:29:34Z
dc.date.available2023-09-05T12:20:19Z
dc.date.created2022-08-19T01:29:34Z
dc.date.issued2022
dc.identifierVELOZO, Camila de Almeida et al. Polymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individuals. The pharmacogenomics journal, v. 22, n. 1, p. 33-38, 2022.
dc.identifier1462-2416
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/54749
dc.identifier10.1038/s41397-021-00254-4
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8654338
dc.languageeng
dc.publisherNature
dc.rightsrestricted access
dc.titlePolymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individuals
dc.typeArticle


Este ítem pertenece a la siguiente institución